The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus

NCT04217291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: SY-004
OTHER: SY-004 matching placebo

Sponsor

Suzhou Yabao Pharmaceutical R&D Co., Ltd.